tenk.fyi

Immix Biopharma, Inc.

IMMXNasdaq· Pharmaceutical Preparations

Price History

Revenue

-

Net Income

-$29.4M

36.2% YoY

EPS

$-0.89

17.1% YoY

Cash

$93.9M

431.2% YoY

FY 2025 · As of 2025-12-31